Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ai Okada

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Blood Advances|May 20, 2026
Atezolizumab for relapsed/refractory extranodal NK/T-cell lymphoma: the phase II NCCH1903/ATTACK trialShinichi Makita, Junji Koya, Yasuhiro Suzuki, et al.
Blood Advances|July 17, 2025
In vivo CRISPR screening reveals cooperation of KMT2D and TP53 deficiencies in B-cell lymphomagenesisKentaro Yamaguchi, Junji Koya, Kota Mizuno, et al.
Veterinary Microbiology|November 19, 2021
Characterization of rabbit hepatitis E virus isolated from a feral rabbitMilagros Virhuez Mendoza, Kenzo Yonemitsu, Keita Ishijima, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 27, 2025
[Development and performance evaluation of a comprehensive genomic profiling assay for hematological malignancies]Yasunori Kogure, Yuji Oshikawa-Kumade, Suguru Fukuhara, et al.
NPJ Genomic Medicine|February 17, 2024
Assessing the efficacy of target adaptive sampling long-read sequencing through hereditary cancer patient genomesWataru Nakamura, Makoto Hirata, Satoyo Oda, et al.
Cell Reports|July 5, 2023
Inter- and intra-tumor heterogeneity of genetic and immune profiles in inherited renal cell carcinomaMariko Tabata, Yusuke Sato, Yasunori Kogure, et al.
Leukemia|May 2, 2025
TP53 and CDKN2A alterations define a poor prognostic subgroup in patients with nodal T follicular helper cell lymphomaYuta Ito, Joji Shimono, Keisuke Kawamoto, et al.
Blood Advances|September 29, 2020
Fusion partner-specific mutation profiles and KRAS mutations as adverse prognostic factors in MLL-rearranged AMLHidemasa Matsuo, Kenichi Yoshida, Kana Nakatani, et al.
Cancer Science|October 30, 2021
Alteration of the immune environment in bone marrow from children with recurrent B cell precursor acute lymphoblastic leukemiaTakashi Mikami, Itaru Kato, James Badger Wing, et al.
Leukemia|April 17, 2024
KRAS G12 mutations as adverse prognostic factors in KMT2A-rearranged acute myeloid leukemiaShinju Iyoda, Kenichi Yoshida, Kota Shoji, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Blood Advances|May 20, 2026
Atezolizumab for relapsed/refractory extranodal NK/T-cell lymphoma: the phase II NCCH1903/ATTACK trialShinichi Makita, Junji Koya, Yasuhiro Suzuki, et al.
Blood Advances|July 17, 2025
In vivo CRISPR screening reveals cooperation of KMT2D and TP53 deficiencies in B-cell lymphomagenesisKentaro Yamaguchi, Junji Koya, Kota Mizuno, et al.
Veterinary Microbiology|November 19, 2021
Characterization of rabbit hepatitis E virus isolated from a feral rabbitMilagros Virhuez Mendoza, Kenzo Yonemitsu, Keita Ishijima, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 27, 2025
[Development and performance evaluation of a comprehensive genomic profiling assay for hematological malignancies]Yasunori Kogure, Yuji Oshikawa-Kumade, Suguru Fukuhara, et al.
NPJ Genomic Medicine|February 17, 2024
Assessing the efficacy of target adaptive sampling long-read sequencing through hereditary cancer patient genomesWataru Nakamura, Makoto Hirata, Satoyo Oda, et al.
Cell Reports|July 5, 2023
Inter- and intra-tumor heterogeneity of genetic and immune profiles in inherited renal cell carcinomaMariko Tabata, Yusuke Sato, Yasunori Kogure, et al.
Leukemia|May 2, 2025
TP53 and CDKN2A alterations define a poor prognostic subgroup in patients with nodal T follicular helper cell lymphomaYuta Ito, Joji Shimono, Keisuke Kawamoto, et al.
Blood Advances|September 29, 2020
Fusion partner-specific mutation profiles and KRAS mutations as adverse prognostic factors in MLL-rearranged AMLHidemasa Matsuo, Kenichi Yoshida, Kana Nakatani, et al.
Cancer Science|October 30, 2021
Alteration of the immune environment in bone marrow from children with recurrent B cell precursor acute lymphoblastic leukemiaTakashi Mikami, Itaru Kato, James Badger Wing, et al.
Leukemia|April 17, 2024
KRAS G12 mutations as adverse prognostic factors in KMT2A-rearranged acute myeloid leukemiaShinju Iyoda, Kenichi Yoshida, Kota Shoji, et al.
Pageof 3